3 Houston universities rise to the top in new list of best Texas schools for 2024

top schools

UH ranked No. 8 in Texas. Photo courtesy of University of Houston

Houston universities are ramping up high quality educational experiences for their students as three local universities earn top 10 ranks for the best Texas colleges in 2024, according to a new report by U.S. News and World Report.

Rice University claimed the top spot in Texas, and ranked No. 17 in the national ranking. Houston's "Ivy League of the South" had an undergraduate enrollment of nearly 4,500 students in fall 2022. In April, Rice's Jones School of Business ranked No. 2 in U.S. News' ranking of the best graduate programs in Texas.

According to Rice's profile, the university also prides itself as a top-tier research institution. In fact, Rice just opened a massive new research facility on campus.

A degree from Rice University in Houston was ranked most valuable in the state of Texas. Rice University

"From your first semester on campus, no matter your major, you'll have the opportunity to conduct research alongside experts," the school said. "You'll be able to apply your skills, gain valuable professional experience and interact with industry leaders as you address real-world issues."

The University of Houston ranked No. 8 in the Texas rankings, and No. 133 in the national report. With a total undergraduate enrollment of nearly 38,000 students in fall 2022, U.S. News says the university has a rich campus culture that encourages students to participate in different organizations and activities.

"Each year, students turn the campus into a town called Fiesta City in time for the Frontier Fiesta, a string of concerts, talent shows, cook-offs and more," U.S. News' overview said. "There are more than 400 student organizations to check out, including fraternities and sororities."

Completing the Texas top 10 is the University of St. Thomas, which ranked No. 216 nationally. The private Catholic university has the smallest fall 2022 undergraduate enrollment out of all three Houston universities: 2,729 students.

Elsewhere in Texas, nearby Texas A&M University in College Station earned the title for the third-best college in Texas, and No. 47 in the nation. That's big news for one of the fastest-growing college towns in the U.S.

U.S. News' top 10 best colleges in Texas in 2024 are:

  • No. 1 – Rice University, Houston
  • No. 2 – University of Texas at Austin
  • No. 3 – Texas A&M University, College Station
  • No. 4 – Southern Methodist University, Dallas
  • No. 5 – Baylor University, Waco
  • No. 6 – Texas Christian University, Fort Worth
  • No. 7 – The University of Texas at Dallas, Richardson
  • No. 8 – University of Houston
  • No. 9 – Texas Tech University, Lubbock
  • No. 10 – University of St. Thomas, Houston

The full rankings can be found on usnews.com.

------

This article originally ran on CultureMap.

From Your Site Articles
Rice has been heralded again by Princeton Review. Photo courtesy of Rice University

Rice University named one of the greatest schools in U.S. in prestigious new report

RICE RISES AGAIN

Just mere weeks after being named the No. 7 university in the nation, a local hall of higher learning has just landed on yet another prestigious list.
Rice University has scored high marks in the Princeton Review's annual survey on the nation's best colleges. The new report as part of "The Best 387 Colleges," its 30th annual snapshot of academic excellence at colleges and universities.

The new report analyzes three decades of reviews on America's institutions of higher education and is based upon reviews submitted by more than 150,000 students nationwide, per a release. The survey lists the top-ranking schools measured in dozens of different categories.

For its 2022 anniversary edition, Princeton Review analyzed which colleges and universities have "the most impressive history of appearances" since 1992.

Notably, per a press release, only four institutions were named to 11 of what the review calls its "Great Lists" — and one of those schools is Rice.

To generate this report, Princeton Review analyzed three criteria: the number of times a college appeared on lists since 1992, its numerical rank on those lists, and the overall consistency of feedback from the college's students over the three decades.

Specifically, Rice ranked on the "Great Lists" in the following categories:

  • great race/class interaction
  • great financial aid
  • great health services
  • great-run colleges
  • most loved colleges
  • great college newspapers
  • great college dorms
  • great quality of life
  • great town-gown relations
  • LGBTQ-friendly
  • happy students

Rice students praised the university's faculty and described a "high quality of life" and are among "the happiest students in the United States," according to a press release.

"I wanted my college years to be both happy and successful," one student wrote in the survey. "And I found no other schools that were as prestigious, but also dedicated to ensuring the happiness of the student body."

As CultureMap previously reported, Niche ranked Rice No. 7 in its latest ratings of the best colleges in the U.S. and No. 1 in Texas.

Rice also ranked No. 136 internationally in The Wall Street Journal/Times Higher Education World University Rankings for 2022.

------

This article originally ran on CultureMap.

The device is lighter than a Band-Aid and could be used as robot skin to track movement and health conditions. Photo via uh.edu

University of Houston professors identify super thin wearable device

Data collecting skin

Imagine a wearable device so thin it's less noticeable and lighter than a Band-Aid but can track and record important health information. According to some University of Houston researchers, you might not need to imagine it at all.

A recent paper, which ran as the cover story in Science Advances, identified a wearable human-machine interface device that is so thin a wearer might not even notice it. Cunjiang Yu, a Bill D. Cook associate professor of Mechanical Engineering at the University of Houston, was the lead author for the paper.

"Everything is very thin, just a few microns thick," says Yu, who also is a principal investigator at the Texas Center for Superconductivity at UH, in a release. "You will not be able to feel it."

The device is reported in the paper to be made of a metal oxide semiconductor on a polymer base. It could be attached to a robotic hand or prosthetic, as well as other robotic devices, that can collect and report information to the wearer.

"What if when you shook hands with a robotic hand, it was able to instantly deduce physical condition?" Yu asks in the release.

The device could also be used to help make decisions in situations that are hazardous to humans, such as chemical spills.

Current devices on the market or being developed are much slower to respond and bulkier to wear, not to mention expensive to develop.

"We report an ultrathin, mechanically imperceptible, and stretchable (human-machine interface) HMI device, which is worn on human skin to capture multiple physical data and also on a robot to offer intelligent feedback, forming a closed-loop HMI," the researchers write in the paper. "The multifunctional soft stretchy HMI device is based on a one-step formed, sol-gel-on-polymer-processed indium zinc oxide semiconductor nanomembrane electronics."

The paper's co-authors, in addition to Yu, include first author Kyoseung Sim, Zhoulyu Rao, Faheem Ershad, Jianming Lei, Anish Thukral, and Jie Chen, who are all from UH; Zhanan Zou and Jianliang Xiao of the University of Colorado; and Qing-An Huang of Southeast University in Nanjing, China.


Soft Wearable Multifunctional Human-Machine Interfaces (HMIs)www.youtube.com

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings